LCB

Live / Allowed — Notice of allowance issued (as of 03 Feb 2026)

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 24 Dec 2024 filing date already counts against anyone who files later.

Record

Serial number
98921336
Mark type
Word mark
Filed
24 Dec 2024
Published for opposition
09 Dec 2025
Attorney of record
Richard Y. Kim

Goods and services

  • Class 005 — Pharmaceuticals: Vaccines; food supplements; vitamin preparations; crude drugs, namely, natural remedy preparations for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; nutraceuticals for use as a dietary supplement; biological preparations for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical pharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical molecular diagnostic reagents for medical use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; biopharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; pharmaceutical preparations, namely, medical pharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; cough syrups for pharmaceutical purposes; lozenges for pharmaceutical purposes; cachets for pharmaceutical purposes; chemico-pharmaceutical preparations; antibodies for medical purposes and medical laboratory tests; drugs for medical purposes, namely, medical pharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical preparations, namely, antibodies for medical purposes, antibody conjugates and active ingredients and antibody conjugates; chemical reagents for medical use, namely, chemical reagents for linking molecules for medical use; pharmaceutical compositions; extracts of medicinal plants, other than essential oils, for pharmaceutical purposes; pharmaceuticals; medicines for human purposes; pharmaceutical products; antibiotics; anti-cancer preparations; mixed vitamin preparations; chemotherapeutics; pharmaceutical preparations for treatment of rare diseases

Owner

Prosecution history

  • 03 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 09 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 09 Dec 2025 — PUBLISHED FOR OPPOSITION
  • 03 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 12 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 23 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 23 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 23 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 09 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 09 Jul 2025 — NON-FINAL ACTION E-MAILED
  • 09 Jul 2025 — NON-FINAL ACTION WRITTEN
  • 10 Jun 2025 — ASSIGNED TO EXAMINER
  • 03 Jun 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
  • 24 Dec 2024 — NEW APPLICATION ENTERED

View this trademark record on Marksy